Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders

W. Aellig, Z. Bankowski, E. Baumbauer, R. Bruppacher, M. Cone, R. Smith-Cove, M. Debre, I. R. Edwards, J. Gallacher, B. Granbensee, J. Idanpaan-Heikkila, G. Kremer, G. Kreutz, P. Krupp, M. Leski, M. M. Lumpkin, M. Oster, M. Pfeiffer, F. Rocco, F. SauerJ. Schou, S. J. Interpharma, W. Schumann, W. Spiegl, F. Spinelli, K. Sprenger, M. Ten Ham, T. Trenque, J. Venulet, E. Weidmann, J. M. Weiss, K. L. Wood

Research output: Contribution to journalArticle

Abstract

This paper is the report of a meeting held in Geneva under the auspices of the Council for International Organizations of Medical Sciences (CIOMS) on 4-5 June 1996. It contains definitions of terms used in reporting adverse drug reactions of the system/organ class renal and urinary system disorders and basic requirements for their use.

Original languageEnglish
Pages (from-to)203-211
Number of pages9
JournalPharmacoepidemiology and Drug Safety
Volume6
Issue number3
DOIs
Publication statusPublished - May 1997

Keywords

  • Glomerular vasomotor disorder
  • Glomerulonephritis
  • Nephritis interstitial acute and chronic
  • Nephropathy analgesic
  • Nephropathy toxic
  • Nephrotic syndrome
  • Renal failure
  • Renal failure (intrinsic) acute
  • Renal tubular disorder
  • Renal vasculitis
  • Urinary retention.

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders'. Together they form a unique fingerprint.

  • Cite this

    Aellig, W., Bankowski, Z., Baumbauer, E., Bruppacher, R., Cone, M., Smith-Cove, R., Debre, M., Edwards, I. R., Gallacher, J., Granbensee, B., Idanpaan-Heikkila, J., Kremer, G., Kreutz, G., Krupp, P., Leski, M., Lumpkin, M. M., Oster, M., Pfeiffer, M., Rocco, F., ... Wood, K. L. (1997). Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders. Pharmacoepidemiology and Drug Safety, 6(3), 203-211. https://doi.org/10.1002/(SICI)1099-1557(199705)6:3<203::AID-PDS265>3.0.CO;2-I